Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 151, Malianwa North Road, Haidian District, Beijing 100193, China.
Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 151, Malianwa North Road, Haidian District, Beijing 100193, China.
Eur J Pharm Sci. 2018 Nov 1;124:266-272. doi: 10.1016/j.ejps.2018.08.043. Epub 2018 Sep 4.
Drug-loaded nanoparticles utilizing amphiphilic molecules as nanocarriers were developed broadly for nanoscale drug delivery system. Linear amphiphilic molecule (PEGC) based on PEG and alkyl chain was designed and synthesized. To study the influence of alkyl chain on antitumor activity, 10-hydroxycamptothecin (HCPT) was selected as the hydrophobic drug, amphiphilic molecule (PEGC) and hydrophilic PEG (PEG) were applied as nanocarriers to form HCPT-loaded nanoparticles (HCPT/PEGC NPs and HCPT/PEG NPs). These two nanoparticles presented high drug-loading content, stability, but different release manner and antitumor efficacy. The HCPT/PEGC NPs existed slower release manner but higher antitumor activity than HCPT/PEG NPs, IC value was decreased approximately 8.5-fold against 4T1 cells in vitro. Moreover, the antitumor efficacy of HCPT/PEGC NPs on 4T1-bearing mice was promoted significantly, the inhibition rate based on average tumor weight was 1.5-fold higher than HCPT/PEG NPs, besides, HCPT/PEGC NPs exhibited better tumor accumulation than HCPT/PEG NPs. These results suggested alkyl chain affect the antitumor activity significantly due to nanoparticles decorated with alkyl chains existing higher endocytosis efficacy to cells. According to the enhanced antitumor efficacy, it was suggested that HCPT/PEGC NPs showed the potential application for cancer therapy in clinic, and alkyl chains should be considered for designing biomaterials.
利用两亲性分子作为纳米载体的载药纳米粒子被广泛开发用于纳米尺度的药物传递系统。设计并合成了基于聚乙二醇(PEG)和烷基链的线性两亲性分子(PEGC)。为了研究烷基链对抗肿瘤活性的影响,选择 10-羟基喜树碱(HCPT)作为疏水性药物,两亲性分子(PEGC)和亲水性 PEG(PEG)作为纳米载体,形成 HCPT 载药纳米粒子(HCPT/PEGC NPs 和 HCPT/PEG NPs)。这两种纳米粒子具有较高的载药含量、稳定性,但释放方式和抗肿瘤活性不同。HCPT/PEGC NPs 的释放方式较慢,但抗肿瘤活性高于 HCPT/PEG NPs,体外对 4T1 细胞的 IC 值降低了约 8.5 倍。此外,HCPT/PEGC NPs 在荷瘤小鼠中的抗肿瘤疗效显著增强,基于平均肿瘤重量的抑制率比 HCPT/PEG NPs 高 1.5 倍,此外,HCPT/PEGC NPs 比 HCPT/PEG NPs 具有更好的肿瘤积累。这些结果表明,由于烷基链修饰的纳米粒子具有更高的细胞内吞效率,烷基链显著影响了抗肿瘤活性。根据增强的抗肿瘤疗效,提示 HCPT/PEGC NPs 具有在临床上用于癌症治疗的潜力,并且在设计生物材料时应考虑烷基链。